Medicine and Dentistry
COVID-19
100%
Therapeutic Procedure
92%
Dyspnea
66%
Major Depressive Episode
55%
Health
54%
Hospital
51%
Treatment Resistant Depression
46%
Analysis
40%
Randomized Controlled Trial
37%
Prospective Cohort Study
37%
Post-COVID-19
35%
Single Drug Dose
33%
Minocycline
33%
Mental Health
33%
Psilocybine
33%
Systematic Review
33%
Network Meta-Analysis
33%
Cohort Analysis
33%
Lung
33%
Patient
33%
Montgomery-Åsberg Depression Rating Scale
26%
Spontaneous Remission
17%
Symptom
15%
Adult
14%
Age
13%
Adverse Event
13%
Sleep
11%
Follow up
11%
Association
10%
Anxiety
10%
Disease
10%
Arm
9%
UK Biobank
9%
middle age
7%
Clinician
7%
Actigraphy
7%
Least Square Analysis
6%
Severe Depression
6%
Dizziness
6%
Incidence
6%
Automutilation
6%
Headache
6%
Nausea
6%
Body Mass Index
6%
Nursing and Health Professions
Patient
82%
Hospital Admission
47%
Hospitalization
47%
Female
43%
Hospital
38%
Prospective Cohort Study
37%
Quality of Life
33%
Older Adult
33%
Cross-Sectional Study
33%
Patient with Congestive Heart Failure
33%
Control
33%
Major Depression
24%
Biobank
13%
Devices
11%
Adult
11%
Actimetry
10%
Pittsburgh Sleep Quality Index
10%
Recording
6%
Hospital Discharge
6%
Body Mass
6%
Clinical Assessment
5%
Clinical Global Impression Scale
5%
Hamilton Depression Rating Scale
5%
Standard
5%
Randomization
5%
Neuroscience
Randomized Controlled Trial
46%
Major Depressive Disorder
36%
Minocycline
33%
Treatment-Resistant Depression
33%
Cardiovascular System
33%
Psychiatry
33%
CD8
33%
Cognitive Disorders
25%
Ethnicity
25%
CD4
25%
Anti-Inflammatory
11%
C-Reactive Protein
8%
Body Mass Index
8%
Mechanical Ventilation
8%
Beck Depression Inventory
7%
Mood Disorder
5%
Clinical Assessment
5%
Ketamine
5%
Tetracycline Antibiotics
5%
